Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06275919
Status:
RECRUITING
Last Update Posted:
2024-03-15
First Post:
2024-02-07
Brief Title:
Regorafenib for Recurrent Grade 2 and 3 Meningioma MIRAGE Trial
Sponsor:
Organization:
Istituto Oncologico Veneto IRCCS